Time For American Healthcare REIT Investors To Explore Their Legal Options

Rhea-AI Summary

Shepherd Smith Edwards and Kantas is offering free consultations to American Healthcare REIT (NYSE:AHR) investors following a 3% share price drop on August 6, 2024. AHR, formed from the merger of Griffin-American Healthcare REIT III, IV, and American Healthcare Investors, debuted on the NYSE in February 2024 with a 56 million share IPO at $12/share. Legacy investors, however, had purchased 66 million shares at $40/share.

The REIT's portfolio, valued at $4.6B in September 2023, includes medical office buildings, skilled nursing facilities, and hospitals. Concerns have arisen about potential broker misconduct in recommending AHR, given its high commissions and fees. Investors may explore legal options for recovery, as the firm has previously helped recoup millions for clients affected by negligent stockbrokers.

Positive

• AHR's portfolio was valued at $4.6B in September 2023, indicating substantial assets
• The company successfully completed its IPO and listing on the NYSE in February 2024

Negative

• AHR's share price dropped 3% on August 6, 2024
• Legacy investors purchased shares at $40, while the IPO price was only $12, representing a significant loss
• Quarterly distributions were reduced for Class T and Class I common stockholders in March 2023
• The company suspended its share repurchase plan in 2022
• Comrit made a third-party tender offer to buy shares at an 8% reduction

News Market Reaction – AHR

+3.09%

+3.09% Session move

In the trading session that priced this news, AHR gained 3.09%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

As Share Price Falls, Filing A Broker Fraud Claim May Be Best Chance For Financial Recovery

HOUSTON, Aug. 13, 2024 /PRNewswire/ -- Shepherd Smith Edwards and Kantas (investorlawyers.com) is offering free, no obligation case consultations to American Healthcare REIT (NYSE:AHR) investors. The real estate investment trust saw its shares drop almost 3% on August 6, 2024 as the lock-up period for legacy non-traded REIT shareholders concluded. A product of the merger between Griffin-American Healthcare REIT III, Griffin-American Healthcare REIT IV, and American Healthcare Investors, in February 2024, AHR arrived on the New York Stock Exchange with a 56 million share/IPO at $12/share. Meanwhile, legacy investors had purchased their 66 million shares for $40/share. (American Healthcare REIT's estimated net asset value (NAV) for Class I and Class T common stock in March 2023 following a 4-1 reverse stock split was $31.40/share. )

This real estate investment trust has a portfolio made up of medical office buildings, skilled nursing facilities, senior housing, and hospitals collectively valued last September 2023 at about $4.6B. Earlier this year, Comrit made a third-party tender offer looking to buy 228,136 of the REIT's shares at a %8% reduction. There was also the suspension of American Healthcare REIT's share repurchase plan in 2022 (barring requests related to qualifying disability or death). March 2023, quarterly distributions were reduced for Class T and Class I common stockholders.

Many investors are wondering whether their brokers may have improperly recommended American Healthcare REIT. Even non-traded REITs, which are generally available to retail investors, may be an unsuitable investment recommendation for someone depending on their age, risk tolerance level, investing goals, and experience.

REITs tend to garner high commissions (up to 15%) and fees for financial advisors. This can compel them to inappropriately market these alternative investments to inexperienced investors and conservative retirees. Due diligence failures, breach of fiduciary duty, and supervisory failures by the broker-dealer can also lead to the unsuitable exposure to these investments which, in turn, can result in significant losses.

How To Pursue Damages For Your American Healthcare REIT Losses

https://youtu.be/AJg85qIL8Ok?si=FJeUVsR7U9MuR4_O

Contact Our American Healthcare REIT Loss Law Firm Today

Over the years, we have helped thousands of investors to collectively recoup many millions of dollars through arbitration, mediation, and litigation from negligent and reckless stockbrokers and their firms.
Call (800) 259-9010 or fill out this form. We represent investors all over the United States.

View original content to download multimedia:https://www.prnewswire.com/news-releases/time-for-american-healthcare-reit-investors-to-explore-their-legal-options-302220236.html

SOURCE Shepherd Smith Edwards & Kantas LLP

FAQ

What caused the recent drop in American Healthcare REIT (AHR) stock price?

American Healthcare REIT (AHR) saw its shares drop almost 3% on August 6, 2024, as the lock-up period for legacy non-traded REIT shareholders concluded.

What was the IPO price for American Healthcare REIT (AHR) in February 2024?

American Healthcare REIT (AHR) had its IPO in February 2024 with 56 million shares priced at $12 per share.

How much did legacy investors pay for American Healthcare REIT (AHR) shares?

Legacy investors of American Healthcare REIT (AHR) had purchased their 66 million shares for $40 per share, significantly higher than the IPO price.

What is the estimated value of American Healthcare REIT's (AHR) portfolio?

American Healthcare REIT's (AHR) portfolio, consisting of medical office buildings, skilled nursing facilities, senior housing, and hospitals, was valued at approximately $4.6 billion in September 2023.

What actions has American Healthcare REIT (AHR) taken that may concern investors?

American Healthcare REIT (AHR) suspended its share repurchase plan in 2022 and reduced quarterly distributions for Class T and Class I common stockholders in March 2023, which may be concerning for investors.